May 30 (Reuters) - Sierra Oncology Inc SRRA.O :
* Sierra Oncology granted US and EU patents for Chk1 inhibitor SRA737
* Sierra Oncology Inc - selection patent issued for sra737 covers compound explicitly and extends initial protection out to 2033 Source text for Eikon: ID:nCNWwzGcra Further company coverage: SRRA.O